| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 248 | 243 | 294 | 246 | | Cost of Revenue | 108 | 77 | 139 | 360 | | | Gross Profit | 140 | 166 | 155 | (113) | | | Operating Expenses | | Research Development | 701 | 1,138 | 437 | 446 | | Selling General and Administrative | 454 | 624 | 747 | 849 | | Non Recurring | (4,794) | 137 | 4,657 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,124) | (1,733) | (5,686) | (1,409) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,629) | (26,751) | (12,731) | (4,658) | | Earnings Before Interest And Taxes | 1,150 | (28,484) | (18,417) | (6,066) | | Interest Expense | 2,355 | 953 | 583 | 127 | | Income Before Tax | (1,204) | (29,437) | (19,000) | (6,193) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (37,481) | (29,437) | (19,000) | (6,193) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,204) | (29,437) | (19,000) | (6,193) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,204) | ($29,437) | ($19,000) | ($6,193) |
|
0.51% Nasdaq 
Income Statement
